Search filters
Filters
Clear All

Phase

  • 5
  • 10
  • 16
  • 2
  • 172
  • 205
  • 131
  • 3
  • 202

Found 205 Type 2 Diabetes Mellitus trials

A listing of Type 2 Diabetes Mellitus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

rEST study

99 years and younger
All genders
The purpose of this post market study is to collect clinical data on the safety and effectiveness of the remed System in a real-world setting.
Learn More

MOVE-LVAD II

99 years and younger
All genders
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
Learn More

EMAS

99 years and younger
All genders
Please see section 2.3 of the full protocol Please see section 2.3 of the full protocol Please see section 2.3 of the full protocol
Learn More

ATHENA

99 years and younger
All genders
A research study looking into how ziltivekimab works compared to placebo in people with heart failure and inflammation
Learn More

MyPEAK-1

99 years and younger
All genders
Please see section 2 of the full protocol Please see section 2 of the full protocol Please see section 2 of the full protocol
Learn More

MRI: O2 v Room Air

99 years and younger
All genders
To determine the response of SkM OxPhos to supplemental oxygen in HFpEF noting that an increase in SkM OxPhos with supplemental oxygen suggests the presence of mitochondrial functional reserve. Change in SkM OxPhos on CrCEST in response to supplemental oxygen Change in intramuscular perfusion with supplemental oxygen as compared to …
Learn More

POTs IgPro20_3010

99 years and younger
All genders
This is a prospective, phase 3, multicenter, double-blind, randomized placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of repeat doses of IgPro20 in subjects with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome). Eligible subjects will be randomized in a 2:1 ratio to receive subcutaneous (SC) infusions of IgPro20 …
Learn More

COMPASSHER2

99 years and younger
All genders
CompassHER2 RD (A011801) is a randomized trial in patients with residual disease after a predefined course of neoadjuvant HER2-directed treatment.
Learn More

NRG-BR009

99 years and younger
All genders
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence …
Learn More

BHB-T cells

18-99 years
Accepts healthy volunteer
All genders
The aim of this study is to biobank blood and stool samples of healthy individuals receiving β-hydroxybutyrate (BHB) supplementation. Additionally, this study will determine whether BHB supplementation increases serum BHB levels and leads to changes in T cell phenotype, including composition (i.e. CD4/CD8), and cytokine secretion. BHB supplementation will be …
Learn More
61 - 70 of 205